Status:
COMPLETED
Biomarkers for Oral Cancer
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Lichen Planus
Oral Leukoplakia
Eligibility:
All Genders
18-110 years
Brief Summary
The purpose is to determine the extent of genetic damage in oral mucosal lesions ascertained in the study, whether specific genotypes are associated with genetic damage observed in the oral mucosal le...
Detailed Description
This longitudinal research project is part of a long-term effort by the National Cancer Institute and the National Institute of Dental and Craniofacial Research to improve modalities for prevention, e...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Patients with white, red, or white and red lesions in the oral cavity and oropharynx as identified by the participating dentist.
Exclusion
Key Trial Info
Start Date :
August 28 1996
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 29 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00341497
Start Date
August 28 1996
End Date
July 29 2025
Last Update
July 31 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
U.C.S.F./ Vterans Affairs Medical Center
San Francisco, California, United States, 94143
2
VA Medical Center, Washington D.C.
Washington D.C., District of Columbia, United States, 20422
3
VA Medical Ctr, Atlanta
Atlanta, Georgia, United States
4
Veterans Affairs, Danville
Danville, Illinois, United States